NCT02250014View on ClinicalTrials.gov

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 5, 2015

Primary Completion Date

December 1, 2017

Study Completion Date

December 21, 2020

Conditions
Recurrent Prostate CancerStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Interventions
PROCEDURE

cryotherapy

Undergo cryotherapy

BIOLOGICAL

sargramostim

Given subcutaneously

Trial Locations (1)

80045

University of Colorado Cancer Center, Aurora

Sponsors

Collaborators (1)

EDAP TMS S.A.
All Listed Sponsors
collaborator

EDAP TMS S.A.

INDUSTRY

lead

University of Colorado, Denver

OTHER